Skip to main content
. Author manuscript; available in PMC: 2018 Jul 27.
Published in final edited form as: Radiother Oncol. 2017 Dec 14;128(1):154–160. doi: 10.1016/j.radonc.2017.11.028

Table 1.

Distribution of patient, tumor, and treatment factors for entire cohort (N = 480).

Characteristic Parameter IMRT (N = 334) PBT (N = 146) P value
Age (years) Mean, Median (Minimum-Maximum) 59.0, 60 (26 – 82) 61.3, 64 (26 – 76) 0.018
PTV (cc) Mean, Median (Minimum-Maximum) 707, 653 (112 – 2554) 552, 506 (174 – 1727) <0.001
Gender, n (%) Female 40 (12) 15 (10) 0.59
Male 294 (88) 131 (90)
Stage, n (%) I 1 (0) 4 (3) 0.09
IIA 115 (34) 46 (32)
IIB 10 (3) 8 (5)
III 196 (59) 82 (56)
IVA 12 (4) 6 (4)
KPS, n (%) 70 13 (4) 2 (1) 0.25
80–100 321 (96) 144 (99)
Tumor location, n (%) Upper-Middle 19 (6) 6 (4) 0.47
Lower 315 (94) 140 (96)
Induction chemotherapy, n (%) No 205 (61) 96 (66) 0.36
Yes 129 (39) 50 (34)
Histology, n (%) Adenocarcinoma 313 (94) 140 (96) 0.14
SCC 21 (6) 5 (3)
Other 0 1 (1)

Abbreviations: IMRT = intensity-modulated radiation therapy, PBT = proton beam therapy, PTV = planning target volume, KPS = Karnofsky performance status, SCC = Squamous cell carcinoma, RT = radiation therapy.